mycophenolate mofetil [CellCept]
Sponsors
Hoffmann-La Roche
Conditions
Heart TransplantationKidney TransplantationLiver TransplantationMyasthenia Gravis Generalised
Phase 3
A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients
CompletedNCT00048152
Start: 2000-12-31End: 2006-03-31Updated: 2016-11-02
A Continuation Study to Assess the Effect of CellCept in Patients With Myasthenia Gravis.
CompletedNCT00408213
Start: 2004-06-30End: 2007-09-30Target: 136Updated: 2008-05-23
Phase 4
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant
CompletedNCT00118742
Start: 2005-08-31End: 2008-12-31Updated: 2010-08-03
Kidney Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Kidney Transplant Recipients
CompletedNCT00121810
Start: 2003-08-31End: 2009-11-30Updated: 2011-04-15
Heart Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Heart Transplant Recipients
TerminatedNCT00121784
Start: 2005-10-31End: 2006-08-31Updated: 2016-11-02
Pharmacogenetic Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.
CompletedNCT00337493
Start: 2005-12-31End: 2008-01-31Updated: 2012-09-17
A Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients Switched From EC-MPS.
TerminatedNCT00420472
Start: 2007-03-31Updated: 2007-11-20
A Study of the Impact of an Early Biopsy in Patients Treated With CellCept (Mycophenolate Mofetil) After Kidney Transplantation
CompletedNCT00817687
Start: 2009-01-31End: 2012-01-31Updated: 2012-07-09